Abstract SARS-CoV-2, a novel coronavirus, is the agent responsible for the COVID-19
pandemic and is a major public health concern nowadays. The rapid and global spread of …

Introduction SARS-CoV-2 is a novel virus that causes coronavirus disease-19 (COVID-19).
Antiviral and immunomodulatory agents have been proposed as potential treatments …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible
coronavirus responsible for the global COVID-19 pandemic. Herein, we provide evidence …

Novel coronavirus (COVID-19 or 2019-nCoV or SARS-CoV-2), which suddenly emerged in
December 2019 is still haunting the entire human race and has affected not only the …

Common manifestations of COVID-19 are respiratory and can extend from mild symptoms to
severe acute respiratory distress. The severity of the illness can also extend from mild …

COVID-19 pandemic mitigation strategies are mainly based on social distancing measures
and healthcare system reinforcement. However, many countries in Europe and elsewhere …

Abstract Purpose of Review To describe the possible neuroinvasion pathways of Severe
Acute Respiratory Syndrome-related Coronavirus-2 (SARS-CoV-2), the virus responsible for …

Abstract The coronavirus disease‑2019 (COVID‑19) pandemic, caused by the new
coronavirus SARS‑CoV‑2, has spread around the globe with unprecedented consequences …

The ongoing COVID-19 pandemic, periodic recurrence of viral infections, and the
emergence of challenging variants has created an urgent need of alternative therapeutic …

Azithromycin has rapidly been adopted as a repurposed drug for the treatment of COVID-19,
despite the lack of high-quality evidence. In this review, we critically appraise the current …